Modeling Immune Cytotoxicity for Cholangiocarcinoma with Tumor-Derived Organoids and Effector T Cells

Scientists developed a co-culture method with patient-derived cholangiocarcinoma organoids and immune cells, which could represent anti-cancer immunity in vitro.